Lin L - Search Results

1

TRIM29 negatively controls antiviral immune response through targeting STING for degradation.

Li Q, Lin L, Tong Y, Liu Y, Mou J, Wang X, Wang X, Gong Y, Zhao Y, Liu Y, Zhong B, Dai L, Wei YQ, Zhang H, Hu H. Li Q, et al. Among authors: lin l. Cell Discov. 2018 Mar 20;4:13. doi: 10.1038/s41421-018-0010-9. eCollection 2018. Cell Discov. 2018. PMID: 29581886 Free PMC article.

2

Erratum: Author Correction to: TRIM29 negatively controls antiviral immune response through targeting STING for degradation.

Li Q, Lin L, Tong Y, Liu Y, Mou J, Wang X, Wang X, Gong Y, Zhao Y, Liu Y, Zhong B, Dai L, Wei YQ, Zhang H, Hu H. Li Q, et al. Among authors: lin l. Cell Discov. 2018 May 31;4:25. doi: 10.1038/s41421-018-0031-4. eCollection 2018. Cell Discov. 2018. PMID: 29873323 Free PMC article.

3

Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.

Lin L, Hu X, Zhang H, Hu H. Lin L, et al. Front Immunol. 2019 Jun 20;10:1398. doi: 10.3389/fimmu.2019.01398. eCollection 2019. Front Immunol. 2019. PMID: 31281318 Free PMC article. Review.

4

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.

Yu H, Lin L, Zhang Z, Zhang H, Hu H. Yu H, et al. Among authors: lin l. Signal Transduct Target Ther. 2020 Sep 21;5(1):209. doi: 10.1038/s41392-020-00312-6. Signal Transduct Target Ther. 2020. PMID: 32958760 Free PMC article. Review.

5

TRIM55 promotes noncanonical NF-κB signaling and B cell-mediated immune responses by coordinating p100 ubiquitination and processing.

Lin L, Yu H, Li L, Yang W, Chen X, Gong Y, Lei Q, Li Z, Zhou Z, Dai L, Zhang H, Hu H. Lin L, et al. Sci Signal. 2023 Oct 10;16(806):eabn5410. doi: 10.1126/scisignal.abn5410. Epub 2023 Oct 10. Sci Signal. 2023. PMID: 37816088

6

Systemic lupus erythematosus: pathogenesis and targeted therapy.

Su X, Yu H, Lei Q, Chen X, Tong Y, Zhang Z, Yang W, Guo Y, Lin L. Su X, et al. Among authors: lin l. Mol Biomed. 2024 Oct 30;5(1):54. doi: 10.1186/s43556-024-00217-8. Mol Biomed. 2024. PMID: 39472388 Free PMC article. Review.

7

Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome.

Lin L, Yu H, Xie X, Lei Q, Chen X, Su X, Wang X, Zhang S, Yang W. Lin L, et al. Am J Cancer Res. 2024 Jun 15;14(6):2731-2754. doi: 10.62347/GIGO3446. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005680 Free PMC article.

8

Sodium-glucose cotransporter 2 inhibitors and contrast-induced nephropathy risk: a meta-analysis.

Fan G, Lin L, Zuo H, Yan R, Xu C. Fan G, et al. Among authors: lin l. Eur J Clin Pharmacol. 2024 Dec 27. doi: 10.1007/s00228-024-03799-y. Online ahead of print. Eur J Clin Pharmacol. 2024. PMID: 39729107 Review.

9

The Use of Acetazolamide to Prevent Acute Kidney Injury in Patients with Cancer on High-Dose Methotrexate Treatment: A Retrospective Pilot Analysis.

Lin L, Batt T, Peterson GM. Lin L, et al. Clin Pract. 2024 Nov 28;14(6):2601-2607. doi: 10.3390/clinpract14060205. Clin Pract. 2024. PMID: 39727793

10

Global and regional trends and projections of chronic pain from 1990 to 2035: Analyses based on global burden of diseases study 2019.

Zhu M, Zhang J, Liang D, Qiu J, Fu Y, Zeng Z, Han J, Zheng J, Lin L. Zhu M, et al. Among authors: lin l. Br J Pain. 2024 Dec 24:20494637241310697. doi: 10.1177/20494637241310697. Online ahead of print. Br J Pain. 2024. PMID: 39726775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,944 results

Search Page

Filters